Navigation Links
KMK Consulting, Inc. Expands Presence in Boston to Help Biotechnology Companies from Pre-Launch to Commercialization
Date:7/9/2019

KMK Consulting, Inc. announced the expansion of the company’s footprint in the biotechnology hub of Cambridge, MA. This expansion strengthens KMK’s presence for the sales, support, and delivery of commercial operations, primary market research, and sales force effectiveness consulting for the biotechnology corridor. With this expansion, KMK can better meet the needs of biotech companies before and during the commercialization process with customizable systems and software, high quality onsite support, and service model transparency.

“You only get one chance at a successful launch,” said Jing Yu, Director of KMK’s biotechnology practice and head of the Cambridge office. “By adding local resources, we are better positioned to provide the synergy that is essential in the commercialization process, from primary market research to building out a sales team. Because KMK is a one-stop shop, we work along the pre-launch-to-commercial spectrum to increase every chance of your product’s success.”

“Successful launches start with a thorough understanding of key stakeholders--beginning with the patient,” said Greg Chu, Principal of KMK’s Market Research practice. “With more people in the Boston area, we are now positioned to deliver the deep customer insights we have become known for to a broader base of customers in the region.”

“Our biotechnology commercial operations practice is expanding,” said KMK President, Michael Karbachinskiy. “With nearly twenty years of experience helping biopharma companies serve more patients and sell more products, KMK’s expertise in connecting the dots along the commercialization process puts us in a prime position to help biotech businesses thrive.”

The Cambridge office is KMK’s fourth location including the Morristown, NJ headquarters, and offices in Dalian, China, and Gujurat, India.

About KMK Consulting, Inc.
KMK Consulting, Inc. was founded in 2000 with a mission to make analytics accessible. By closing the gap between technology and analytics, KMK helps life sciences companies do what they do best: focus on patients. Our analytic teams work on- or off-site to deliver customizable software and consulting services across commercial operations in the areas of advanced analytics, market research, health economics and outcomes research, sales force effectiveness, and data warehousing and reporting. As a one-stop shop for commercial operations support, KMK turns complex data into actionable human decisions and real-world business solutions. KMK carries a reputation of quality and reliability that extends throughout its 160+ person organization and company culture.

Read the full story at https://www.prweb.com/releases/kmk_consulting_inc_expands_presence_in_boston_to_help_biotechnology_companies_from_pre_launch_to_commercialization/prweb16418573.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. IMMUNE 3D® Expands Platform into New Disease Areas and Enters into Drug Discovery
2. Leading Boston-Based Conference Company and Publisher Expands Portfolio Internet of Things (IoT)
3. RxS Expands its Office Footprint to Accommodate Rapid Growth
4. Cybrexa Therapeutics Expands Scientific Advisory Board Ahead of IND Filing
5. Cryo-Cell International Expands Its Board Of Directors
6. HireVue Expands C-Suite With Strategic Sales And Marketing Hires To Accelerate Growth Globally
7. Sandata Technologies Expands Leadership Team with Product Management Executive
8. Led by New Patents to Identify Malicious Intent on Mobile Devices, BioCatch Significantly Expands its IP Portfolio
9. Eliassen Groups Biometrics & Data Solutions Team Expands to Support Growth
10. higi secures over $40 million of funding - expands growth of the largest retail, omni-channel community health and wellness platform in the nation
11. NXT-ID Expands on Recent Announcement of Strategic Alliance With World Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/29/2020)... COLLEGE, Pa. (PRWEB) , ... January 29, 2020 ... ... in nuclear receptor and in vitro toxicology testing solutions, has announced a record ... in the upcoming weeks, INDIGO showed more than a twenty percent increase in ...
(Date:1/27/2020)... , ... January 27, 2020 , ... ... Chairman. Thorne is a noted investor, tech entrepreneur, and former senior management consultant ... Chairman of Broadline Capital, the global alternative investment firm. , “Chris Thorne ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN ... cells from stem cells. The red blood cells are made utilizing a ... conditions, for transfusion therapy and replaces the need for a human blood donor. ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... , ... January 21, 2020 , ... QCDx , ... biopsy from a simple blood draw, today announced the sale of the proprietary RareScope™ ... Rare Scope will be used in clinical cancer research. , “The RareScope can detect ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... properties for use in harsh environments inside or outside of the human body. ... metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation ...
(Date:1/7/2020)... ... January 06, 2020 , ... EconoFact, ... The Fletcher School at Tufts University, is pleased to announce that it was ... be administered by Tufts University, and will help to expand the scope, exposure ...
(Date:12/31/2019)... ... 31, 2019 , ... At this year's SLAS conference, Visikol will present several ... 3D cell culture , advanced imaging and multiplex analysis . ... steatosis , inflammation and fibrosis as well as a 2D cell ...
Breaking Biology Technology: